Introduction {#sec1}
============

Helminth parasites can persist for long periods of time inside their hosts. The effectiveness of these parasites to control host immunity is associated with their ability to trigger and maintain tissue-remodeling Th2 responses rather than inflammatory host-compromising Th1 responses \[[@B1]\]. In fact, this Th2-inducing ability is a helminth-intrinsic feature as evidenced by free-living worms that can condition immune cells towards a Th2 profile \[[@B2]\]. This canonical helminth-induced Th2 response comprises increased secretion of molecules, such as interleukin (IL)-4, IL-5 and IL-13 \[[@B3]\] as well as recently uncovered tissue-derived cytokines like IL-25 \[[@B4]\], IL-33 \[[@B5]\] and thymic stromal lymphopoietin (TSLP): \[[@B6]\] the latter three are produced early in infection, creating a local microenvironment in which T cells can fully polarize into Th2 cells. Once differentiated, Th2 cytokines perform a variety of functions aimed at expelling intestinal worms. This helminth-elicited Th2 response promotes differentiation of plasma cells and IgG~1~ and IgE production, and, in the gut, goblet cell hyperplasia, enhanced mucin secretion and accelerated peristalsis.

This Th2 cytokine response is complemented by cellular components that expand (high numbers in blood) and infiltrate organs where worm parasites dwell. Notably, this includes increased numbers of granulocytes, such as eosinophils \[[@B7]\], basophils \[[@B8]\] and mast cells \[[@B9]\]. Despite the association of these cells with infection with helminths, the precise role of each granulocyte population remains controversial, due largely to the complexity and variety of helminths examined, as well as the life cycle stage of the helminth assessed (larvae versus adults), and host genetics. However, these granulocytes are important initiators, drivers and effectors of Th2 immunity \[[@B12]\].

Mast cells (MCs) are bone marrow derived granulocytes that reside in mucosal tissues and other surfaces (i.e. skin), strategically positioned to respond to environment-derived threats. MCs play diverse roles in a variety of settings such as resistance to skin virus \[[@B15]\] and bacteria \[[@B16]\] by releasing the antimicrobial peptide cathelicidin, maintaining the intestinal epithelial barrier \[[@B17]\], and interacting with other myeloid cells to create a tumor-permissive environment \[[@B18]\]. MCs have the ability to shape the immune response through release of inflammatory cytokines (IL-17 \[[@B19]\] and TNFα \[[@B20]\]) and the Th2-promoting IL-4 \[[@B21]\] and IL-33 \[[@B22]\].

In the context of infection with helminth, early studies described anti-worm features exerted by MCs upon IgE ligation. For instance, MCs are important in the expulsion of intestinal nematodes such as *Heligmosomoides polygyrus* \[[@B22],[@B23]\], *Trichuris muris* \[[@B22]\], *Strongyloides venezuelensis* \[[@B24]\], *Trichinella spiralis* \[[@B25]\] and *Strongyloides ratti* \[[@B26]\]. On the other hand, the role of MCs is controversial with *Nippostrongylus brasiliensis* \[[@B18],[@B25]\]. This suggests that diversity in worm life cycle stages and host may determine the response displayed by MCs during helminth-infections and disease outcome.

Rats infected with low infective doses of the rat tapeworm, *Hymenolepis diminuta*, harbor adult worms indefinitely. The role of MCs in *H. diminuta*-infected rats has been explored. For example, F344 rats infected with five *H. diminuta* cysticercoids (never expelled) elicit a mild mast cell and IgE response \[[@B27]\] whereas a more prominent MC response occurs in Sprague Dawley rats infected with 35 cysticercoids, of which seldom more than ten helminths were recovered at necropsy \[[@B28]\]. In addition, MCs appear to have a limited role in the WsRC rat response to *H. diminuta* \[[@B29]\], and while a MC response was observed in infected Brown-Norway rats, there was no evidence of worm expulsion \[[@B30]\]. Thus, while evidence of MC activation can be found following infection with *H. diminuta*, this appears to be host- and dose-dependent, and it is far from clear the contribution, if any, of MCs to worm expulsion from the gut \[[@B31]\].

Mice are a highly resistant host and expel *H. diminuta* within 7--10 days of a primary infection. The mouse-*H. diminuta* model has been used to dissect the immunoregulatory circuits elicited by a small intestine-dwelling worm lacking abrasive structures that result in negligible tissue-damage \[[@B32]\]. While we have previously shown that MCs are activated in the mouse following infection, as evidenced by increased serum levels of mast cell protease (MCPT)-1 \[[@B33]\], their role in worm expulsion is not established. Here, we addressed the role of MCs in mice infected with *H. diminuta* by using animals with the *w-sh* mutation that results in suppressed expression of the *kit* molecule and consequently MC-deficiency \[[@B34]\].

Materials and methods {#sec2}
=====================

Mice, parasites and infection {#sec2-1}
-----------------------------

The *H. diminuta* life cycle is maintained by infecting the flour beetle intermediate host (*Tribolium spp.*) through feeding with gravid proglotids collected from adult worms harvested from rats (Harlan laboratories, QC Canada). Five infective cysticercoids collected from infected beetles were orally gavaged in 0.9% NaCl sterile solution into wild-type (WT) and mast cell-deficient mice (Kit^w-sh^). In order to determine any differences in terms of time of expulsion, mice from both groups were killed at 8, 10, 12 and 14 days post-infection (p-i.) and parasites enumerated and worm length determined.

Mast cell protease (MCPT)-1 quantification {#sec2-2}
------------------------------------------

Seven- to eight-week-old male WT mice and age-matched Kit^w-sh^ were orally infected with five csyticercoids of *H. diminuta* and on 8 days p-i., portions of mid-small intestine were excised and homogenized in bovine serum albumin (BSA)-containing PBS (1%) and a protease inhibitor cocktail (Roche) by using beads (50 mg/ml) in a bullet blender. Homogenate samples were diluted (1:100) and MCPT-1 measured by ELISA (eBioscience, San Diego, CA, U.S.A.).

Cell culture {#sec2-3}
------------

At indicated time points, spleens were aseptically removed and passed through a 100 μm mesh (Cell strainer, Falcon U.S.A.). Erythrocyte lysis was achieved by incubating the cells in ammonium chloride buffer, and leukocyte suspensions were adjusted to 3 × 10^6^/ml in RPMI-1640 medium supplemented with 10% FBS (Gibco, U.S.A.), 0.1 mM glutamine (Glutamax, Gibco, U.S.A.) and antibiotics (Pen-Strep solution, Gibco, U.S.A.). Cells were seeded for *in vitro* re-stimulation with concanavalin A (2 μg/ml) for 48 h. Following incubation, cell culture supernatants were collected and frozen (−80°C) for use in ELISA, as previously reported \[[@B35]\].

Small intestine homogenates {#sec2-4}
---------------------------

Three centimeter segments of mid-jejunum from infected WT and Kit^w-sh^ were flushed with sterile ice-cold PBS and immediately placed in protease-containing buffer. Tissue samples were homogenized for 60 s using a tissue homogenizer (Polytron MR2100, Kinematica AG, Switzerland). After centrifugation (3000 rpm/10 min) supernatants were collected and frozen for cytokine measurements.

ELISA sandwich {#sec2-5}
--------------

Canonical Th2 cytokine levels (i.e. IL-4, IL-10 and IL-13) were measured in splenocyte culture supernatants (3 × 10^6^ splenocytes, 2 μg/ml concanavalin A, 48-h incubation at 37°C) and tissue-derived cytokines (i.e. IL-25, IL-33 and TSLP) in jejunum homogenates. ELISAs were conducted following manufacturer's instructions (R&D Systems Inc., Minneapolis, MN, U.S.A.).

Flow cytometry and depletion of neutrophils {#sec2-6}
-------------------------------------------

Neutrophils in spleen cell suspensions were determined by flow cytometry and phenotype was assessed by staining with APC-CD11b, PE-Gr1 and FITC-MHCII (all from Biolegend, U.S.A.), where neutrophils exhibited the phenotype SSC^+^CD11b^+^Gr1^+^MHCII^−^.

When indicated, neutrophils were depleted in Kit^w-sh^ mice by intraperitoneal (i.p.) delivery of anti-Gr1 depleting antibody (Biolegend U.S.A. Clone RB6-8C5). By using this clone, others \[[@B36]\] and we \[[@B40]\] have shown high specificity and effectiveness in terms of neutrophil depletion. Depleting protocol consisted of daily injections of 100 μg of anti-Gr-1 from day 0 to day 5 p-i.

Induction and assessment of experimental colitis {#sec2-7}
------------------------------------------------

Acute colitis was induced by intrarectal (ir.) delivery of 5 mg/mouse of dinitrobenzene sulfonic acid (DNBS, MP Biomedicals, Ohio, U.S.A.) in 100 μl of 50% ethanol. Weight was recorded daily for 3 days, and experimental mice were scored on a macroscopic disease activity score consisting of a 5 point scale based on weight loss, colon length, stool consistency and general appearance as previously \[[@B35]\].

Statistical analysis {#sec2-8}
--------------------

Data are presented as mean ± the standard error of the mean (SEM) and statistical differences were determined by one-way ANOVA followed by post-hoc analysis with Student's *t* test or Kneuman's Keuls test and *P*\<0.05 accepted as a statistically significant difference (Graph Pad prism V5 software, La Jolla, CA, U.S.A.).

Results {#sec3}
=======

Mast cell deficiency causes overgrowth and delayed expulsion of *H. diminuta* {#sec3-1}
-----------------------------------------------------------------------------

*H. diminuta* substantially increased the levels of the MC-specific marker, MCPT-1, in small intestine of WT animals whereas samples from infected Kit^w-sh^ mice showed no increase in MCPT-1 ([Figure 1](#F1){ref-type="fig"}). The tapeworm *H. diminuta* is expelled from the gut of immunocompetent mice within 7--10 days of a primary infection \[[@B32]\]. These findings were confirmed here: only one worm of a five-cysticercoid infection was retrieved on day 8 post-infection (p-i.) and none on day 10 from WT mice ([Figure 2](#F2){ref-type="fig"}A). In contrast, Kit^w-sh^ mice showed altered kinetics of worm expulsion, harboring up to 4 worms at day 8 and 1-2 worms on day 12 ([Figure 2](#F2){ref-type="fig"}A). Notably, in addition to delayed expulsion we observed that worms flushed from intestines of Kit^w-sh^ mice were significantly larger than those from WT mice ([Figure 2](#F2){ref-type="fig"}B). Representative images of collected worms from both experimental groups are shown on [Figure 2](#F2){ref-type="fig"}C. Thus, MCs assist the expulsion of *H. diminuta* worms from the mouse host and restrain increases in helminth biomass.

![Increase in small bowel mast cell protease (MCPT)-1 following infection with *H. diminuta*\
To test if *H. diminuta* infection triggers MCs activation, we measured MCPT-1 levels as putative marker of such activation. Wild-type (WT) and mast cell deficient (Kit^w-sh^) mice were infected, and 8 days later jejunal tissues were excised, homogenized and MCPT-1 determined by ELISA. Data are from one experiment (*n*=4) where \**P*\<0.05 compared against strain-matched uninfected animals.](bsr-38-bsr20180687-g1){#F1}

![Kit^w-sh^ mice display delayed expulsion of *H. diminuta*\
Wild-type (WT) and mast cell-deficient (Kit^w-sh^) mice were infected with 5 cysticercoids of *H. diminuta* by oral gavage. At 8, 10, 12 and 14 days post-infection, mice under deep anesthesia were necropsied, the intestines flushed with ice-cold PBS and recovered worms counted (**A**). Parasites were measured (**B**) and representative images are shown in panel (**C**) (data are mean ± SEM; *n* = 3--8; \**P*\<0.05 compared with time-matched WT mice).](bsr-38-bsr20180687-g2){#F2}

Absence of MCs altered cytokine production in response to *H. diminuta* infection {#sec3-2}
---------------------------------------------------------------------------------

Mice infected with *H. diminuta* display a canonical Th2 response as determined by splenocyte production of IL-4, IL-5, IL-13 and regulatory cytokine IL-10, which typically peak at ∼8 days p-i. We sought to determine the cytokine profile produced by splenocytes and compare these to those produced by mice lacking MCs. Mitogen-stimulated splenocytes from infected WT mice resulted in the expected \[[@B41]\] pattern of cytokine release with peak production on day 8 p-i. ([Figure 3](#F3){ref-type="fig"}). Splenocytes from Kit^w-sh^-infected mice also displayed a Th2 response, which while not radically different from the pattern of WT mice showed distinct differences ([Figure 3](#F3){ref-type="fig"}). Thus, the peak output of IL-4 and IL-13 occurred on day 4 p-i., there was a general reduction in IL-4, IL-5 and IL-13 on day 8 p-i. compared with WT cells and there appeared to a compensatory rebound on day 12 p-i. ([Figure 3](#F3){ref-type="fig"}). With respect to splenic IL-10 ([Figure 3](#F3){ref-type="fig"}C), the most notable difference between WT and Kit^w-sh^ mice was the reduced levels at day 12 p-i. in the MC-deficient mice, perhaps hinting at reduced recovery and resetting of the immune homeostatic set-point.

![Spleen cells from infected Kit^w-sh^ mice produced an altered pattern of Th2 cytokines\
On the indicated days post-infection with 5 cysticercoids of *H. diminuta*, 3 × 10^6^ spleen cells were stimulated with conA (2 μg/ml) for 48 h, cell-free supernatant collected and (**A**) IL-4, (**B**) IL-5, (**C**) IL10 and (**D**) IL-13 levels determined by ELISA. Data are mean ± SEM from one experiment of three experiments yielding similar results (*n* = 3--4 each experiment) (\**P*\<0.05 compared with time-matched WT samples).](bsr-38-bsr20180687-g3){#F3}

Tissue-derived cytokines prime resident cells to initiate and amplify immune responses. In the context of intestinal helminth infections, secretion of IL-25, IL-33 and TSLP promote the Th2 response \[[@B22]\]. We measured these cytokines in jejunal homogenates from uninfected mice as well as various time points p-i. in both experimental groups. MCs appear to be important in the basal expression of all three epithelial-derived alarmins, as jejunum from uninfected mice had very low levels compared with gut from WT mice ([Figure 4](#F4){ref-type="fig"}). In contrast, with the exception of reduced IL-33 at day 4 p-i. in the Kit^w-sh^ gut, there were no other remarkable differences between *H. diminuta*-infected WT or MC-deficient mice ([Figure 4](#F4){ref-type="fig"}).

![MCs regulate baseline expression of gut-derived alarmins but not those evoked by infection with *H. diminuta*\
On the indicated days post-infection with 5 cysticercoids of *H. diminuta*, (**A**) IL-25, (**B**) IL33 and (**C**) TSLP were measured in jejunal homogenates by ELISA. Data are mean ± SEM from one representative experiment (*n* = 3--4), two additional experiments were carried out yielding similar results (\**P*\<0.05 compared with time-matched WT samples).](bsr-38-bsr20180687-g4){#F4}

Neutrophils depletion results in accelerated expulsion of *H. diminuta* {#sec3-3}
-----------------------------------------------------------------------

Since Kit^w-sh^ mice harbored worms for longer periods of time but ultimately were capable of expelling the worms, we hypothesized that other cell populations could be recruited to compensate for the lack of MCs. Flow cytometry, revealed to differences between WT and Kit^w-sh^ mice in basal numbers of neutrophils (Gr-1^+^MHCII^−^), but there was a significant expansion of these cells in infected MC-deficient mice ([Figure 5](#F5){ref-type="fig"}). Testing the hypothesis that neutrophils could participate in the coordinated response to expel *H. diminuta* in MC-deficient mice, the neutrophil depleting anti-Gr-1 antibody was administered to Kit^w-sh^-infected mice. Remarkably, this treatment of the Kit^w-sh^-infected mice resulted in complete expulsion of *H. diminuta* by 8 day p-i., while those mice given an isotype-matched antibody all had a worm burden at this time ([Figure 5](#F5){ref-type="fig"}B). The accelerated worm expulsion was paralleled by splenomegaly ([Figure 5](#F5){ref-type="fig"}C,D).

![Neutrophil depletion results in splenomegaly and rapid clearance of *H. diminuta* worms\
Spleen cell suspensions from infected Kit^w-sh^ mast-cell deficient mice treated with either isotype control (ISO) antibodies or anti-Gr-1-depleting antibodies were adjusted to 1×10^6^/ml and incubated with blocking anti-CD16/32 and subsequently stained with fluorochrome-conjugated CD11b, Gr-1 and MHC II-specific antibodies. The percentage of neutrophils (Gr-1^+^MHCII^−^) in samples from both experimental groups at indicated time points with representative plots are shown in (**A**). Panel (**B**) shows the number of *H. diminuta* flushed from the small intestine on day 8 post-infection from Kit^w-sh^ neutrophil-depleted mice and Kit^w-sh^ mice with an intact neutrophil population. Splenic weight and cell counts from Kit^w-sh^ mice infected with *H. diminuta* and treated with neutrophil-depleting antibodies are shown in (**C**) and (**D**). Data are mean ± SEM for *n*=5 from one experiment (\**P*\<0.05 compared to time-matched WT counterparts; \#*P*\<0.05 compared to time-matched ISO-treated mice).](bsr-38-bsr20180687-g5){#F5}

Infection with *H. diminuta* protects MC-deficient mice from chemical-induced colitis {#sec3-4}
-------------------------------------------------------------------------------------

We have demonstrated that infection with *H. diminuta* protects mice from DNBS-induced colitis \[[@B41]\]. Employing this validated model, the issue of putative mast cell involvement in the helminth-initiatied inhibition of colitis was tested, noting that the MC-deficient mice were able to eradicate the worm but with slower kinetics than WT mice ([Figure 2](#F2){ref-type="fig"}). Interestingly, we observed comparable anti-colitic protection by *H. diminuta* infection in WT and Kit^w-sh^ mice, as gauged by colon length and macroscopic disease scores ([Figure 6](#F6){ref-type="fig"}A,B).

![Infection with *H. diminuta* suppresses colitis in Kit^w-sh^ mice\
Wild-type and MC-deficient, Kit^w-sh^, mice were infected with 5 cysticercoids of *H. diminuta* (H. dim) 8 days prior to intrarectal delivery of DNBS (5 mg in 100 μl of 50% ethanol). Seventy-two hours later, colon length was measured (**A**) and a macroscopic disease score calculated (**B**). Data are mean ± SEM and *n* = 3--4 from one representative experiment of experiments (\**P*\<0.05 as compared with control group and \# compared against DNBS alone group).](bsr-38-bsr20180687-g6){#F6}

Discussion {#sec4}
==========

Helminth parasites evoke Th2 responses within their hosts, which once established direct host protection \[[@B42]\], worm expulsion \[[@B43],[@B44]\] and chronicity of the infection \[[@B45]\]. Of the various Th2 components, MCs are mucosa-residing cells with a rapid-response function, especially via IgE activation. In our hands, mice lacking MCs had an impaired ability to expel *H. diminuta* worms: Kit^w-sh^ mice retained parasites in the intestine until day 12 p-i., whereas worms were not detected in the gut of WT mice beyond day 10 p-i.

MC hyperplasia is a feature of infection with intestinal worm parasites; in fact, it has been shown that MCs are actively involved in the battle against helminth parasites. Studies addressing the role of MCs following worm-infections show that their importance is parasite--host specific. For example, expulsion of the nematode *T. spiralis* requires MCs, whereas that of *N. brasiliensis* does not. Pioneer studies showed that STAT6-deficient mice could not expel *N. brasiliensis* even in the presence of abundant MCs \[[@B46]\] and a deficiency of MCs resulted in a reduced granulomatous response in rats infected with *N. brasiliensis* \[[@B47]\]. In contrast, larvae *T. spiralis* remained longer in mice lacking MCPT-1, despite having abundant MCs suggesting that MCs promote *T. spiralis* expulsion \[[@B25],[@B48]\]. Complementing these data, we find that MC-deficiency results in increased worm biomass and delayed expulsion of *H. diminuta* from the mouse intestine. Assessing worm biomass and infectivity in rats given 5 *H. diminuta* cysticercoids, Ohno et al. \[[@B29]\] reported no difference in worm biomass between WT and MC-deficient rats following primary infection, whereas upon secondary infection WT expelled a greater percentage of the worm innucolum.

While *kit* signaling is central in MC development, other signals may compensate for its absence in rats and mice. For example, MC-deficient *Ws/Ws* rats infected with *N. brasiliensis* were shown to have MCs, in fact connective tissue MCs rather than mucosal MCs are diminished in this strain \[[@B49]\]. Also, infection of C57BL/6 MC-deficient *w/wv* mice with the nematode *T. spiralis* resulted in the appearance of MCs \[[@B50]\]. Thus, while the lack of MCPT-1 in *H. diminuta*-infected Kit^w-sh^ supports the lack of MCs, the possibility that a subtype of MC arises following infection to contribute to worm expulsion cannot unequivocally be ruled out: such statement awaits an extensive investigation of mast cell markers in this mouse strain.

Given that Kit^w-sh^ mice expelled *H. diminuta* by day 14 p-i., we sought to determine if other cells were mobilized that might compensate for the absent MCs. We assessed neutrophils given their emerging putative role in the host response to infection with helminth parasites, finding them increased in spleens from infected Kit^w-sh^ mice. Many functions have been uncovered for neutrophils in helminthic infections: for example, neutrophils are central in early responses in the skin upon infection with *Litomosoides sigmodontis* \[[@B51]\]. Likewise, *N. brasiliensis* elicits neutrophil infiltration and NET release at the site of infection \[[@B52]\]. Moreover, neutrophil--macrophage cooperation has been described in the clearance of *S. stercolaris* \[[@B53]\] and *N. brasiliensis* \[[@B54]\] from mice. Importantly, neutrophil infiltration is required during the early phases of granuloma formation in response to *Schistosoma japonicum* eggs \[[@B55],[@B56]\]. We observed that Kit^w-sh^ mice depleted of neutrophils presented splenomegaly and clearance of *H. diminuta*. With kinetics similar to WT mice. Others have shown that neutrophil depletion via anti-Gr-1 antibody results in an enhanced Th2 response in the context of chronic helminthic infection \[[@B57]\]. Further, the role of neutrophils on T-cell functions has also been reported. For instance, depleting neutrophils in the context of ocular inflammation resulted in the exacerbated Th/Th17 polarization \[[@B58]\], and neutrophil depletion can enhance intestinal inflammation \[[@B59]\]. In line with this, we speculate that neutrophil depletion enabled T cells to proliferate in a Th2-dominated microenvironment, thereby exaggerating the Th2 response resulting in accelerated expulsion of *H. diminuta*. This speculation requires testing, such as analyses of effector mechanisms associated with *H. diminuta* expulsion (e.g. goblet cell hyperplasia) in neutrophil-depleted mice. Similarly, additional studies are required to test the hypothesis that neutrophils can favor Th2 immunity following infection with helminth parasites, thus contributing to worm eradication.

The use of a model of inflammatory disease shows that infection with helminth parasites, typically in a prophylactic regimen, reduces the severity of disease \[[@B60]\]. Indeed, infection with *H. diminuta* has been repeatedly shown to inhibit DNBS-induced inflammation in mice, whereas B cells \[[@B61]\], alternatively activated macrophages \[[@B62]\] and IL-10 \[[@B41]\] have all been shown to have the potential to mediate the suppression of colitis. Given the complexity of the mucosal immune circuitry, the possibility of MC involvement in *H. diminuta*-evoked suppression of DNBS-colitis was assessed. In contrast with the kinetics of worm expulsion, Kit^w-sh^-infected mice displayed reductions in the severity of DNBS-induced colitis that was not different from that observed in *H. diminuta*-infected WT mice.

In summary, we find that MCs contribute to the rapid expulsion of *H. diminuta* as a primary infection in mice, and this is associated with nuanced changes in the ability of splenocytes to produce Th2 cytokines. In addition, two remarkable observations were made that need further investigation: first, MCs may be critical in the control of the constitutive expression of intestinal IL-25, IL-33 and TSLP; and, second, neutrophils increase in the spleen of *H. diminuta*-infected MC-deficient mice. Finally, the negligible difference in DNBS-disease severity in WT and Kit^w-sh^ mice infected with *H. diminuta* indicates that MCs are not a significant component of the *H. diminuta*-evoked anti-colitic effect.
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